Kathleen Swilik, PA
Physician Assistant · Indianapolis, INNPI 1215549753
Payments from drug & device makers
Across 156 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$578
- Medtronic$302
- Lilly USA, LLC$287
- Pfizer$196
- Teva Pharmaceuticals USA, Inc.$175
- Azurity Pharmaceuticals, Inc.$150
- plus $1K from 32 others
What the payments were for
- Travel & lodging$1445%
- Food & beverage$2,86395%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $578 |
| Medtronic | 5 | $302 |
| Lilly USA, LLC | 20 | $287 |
| Pfizer | 18 | $196 |
| Teva Pharmaceuticals USA, Inc. | 9 | $175 |
| Azurity Pharmaceuticals, Inc. | 7 | $150 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $150 |
| Vertex | 6 | $141 |
| Biogen | 4 | $117 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
| Jazz Pharmaceuticals Inc. | 3 | $69 |
| Axsome Therapeutics, Inc. | 4 | $62 |
| Idorsia Pharmaceuticals US Inc | 4 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Averitas Pharma Inc. | 2 | $43 |
| Valinor Pharma, LLC | 3 | $42 |
| SPR Therapeutics, Inc | 3 | $40 |
| Harmony Biosciences LLC | 2 | $36 |
| Neurocrine Biosciences, Inc. | 1 | $33 |
| UCB, Inc. | 1 | $31 |
| AstraZeneca | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Si-bone, Inc. | 1 | $28 |
| Boston Scientific | 1 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $23 |
| SK Life Science, Inc. | 1 | $21 |
| Argenx US, Inc. | 1 | $19 |
| GRT US Holding, Inc. | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$129
- NURTEC ODT$101
How this compares
$3,015 in reported general payments places this provider in the 85th percentile of 1,955 physician assistant providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 47 | $52,974 |
| Nurtec OdtRimegepant Sulfate | 26 | $43,392 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,200 | $41,486 |
| BelbucaBuprenorphine Hcl | 47 | $34,096 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 957 | $28,355 |
| HorizantGabapentin Enacarbil | 23 | $23,192 |
| OxycontinOxycodone Hcl | 38 | $22,406 |
| MovantikNaloxegol Oxalate | 17 | $19,615 |
| QuviviqDaridorexant Hcl | 34 | $16,830 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $15,062 |
| RelistorMethylnaltrexone Bromide | 12 | $12,595 |
| Pregabalin | 329 | $12,507 |
| Emgality PenGalcanezumab-Gnlm | 11 | $10,377 |
| Oxycodone Hcl | 403 | $9,720 |
| Tizanidine Hcl | 432 | $9,579 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy | $578 | $52,97447 claims |
| PfizerNurtec Odt | $196 | $43,39226 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $79 | $34,09647 claims |
| Redhill Biopharma Inc.Movantik | $15 | $19,61517 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $59 | $16,83034 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in Indianapolis
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lindsay YoderIndianapolis$21K
- Mackenzie LawsonIndianapolis$15K
- Christina RaceIndianapolis$13K
- Zara BogenschutzIndianapolis$12K
- Ashley WorthingtonIndianapolis$11K
- Madison MaloofIndianapolis$10K
- Jason BrownIndianapolis$10K
- Michaela WehrIndianapolis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.